Clear Street LLC Exits Position in Ernexa Therapeutics Inc. (ERNA) via 13G/A Filing

Clear Street LLC has filed a Schedule 13G/A (Amendment No. 1) regarding its holdings in Ernexa Therapeutics Inc. (ERNA). The filing, dated May 20, 2026, and reflecting an event date of May 5, 2026, indicates that Clear Street LLC now holds zero shares of the company's common stock, representing a 0.0% ownership stake. The purpose of this amendment is to formally terminate the filer's reporting obligations. Clear Street LLC noted that its beneficial ownership does not meet or exceed the 5% threshold required for 13G reporting. In fact, the filer clarified that no reporting obligation actually existed at the time of the original filing, and this amendment serves to correct the record and exit the position. The shares were originally held in the ordinary course of business without the intent to influence or change the control of the issuer. This filing effectively closes out Clear Street LLC's reported interest in Ernexa Therapeutics.